Suppr超能文献

DNA-组蛋白交联:形成与修复

DNA-Histone Cross-Links: Formation and Repair.

作者信息

Pachva Manideep C, Kisselev Alexei F, Matkarimov Bakhyt T, Saparbaev Murat, Groisman Regina

机构信息

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada.

Department Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, United States.

出版信息

Front Cell Dev Biol. 2020 Dec 21;8:607045. doi: 10.3389/fcell.2020.607045. eCollection 2020.

Abstract

The nucleosome is a stretch of DNA wrapped around a histone octamer. Electrostatic interactions and hydrogen bonds between histones and DNA are vital for the stable organization of nucleosome core particles, and for the folding of chromatin into more compact structures, which regulate gene expression via controlled access to DNA. As a drawback of tight association, under genotoxic stress, DNA can accidentally cross-link to histone in a covalent manner, generating a highly toxic DNA-histone cross-link (DHC). DHC is a bulky lesion that can impede DNA transcription, replication, and repair, often with lethal consequences. The chemotherapeutic agent cisplatin, as well as ionizing and ultraviolet irradiations and endogenously occurring reactive aldehydes, generate DHCs by forming either stable or transient covalent bonds between DNA and side-chain amino groups of histone lysine residues. The mechanisms of DHC repair start to unravel, and certain common principles of DNA-protein cross-link (DPC) repair mechanisms that participate in the removal of cross-linked histones from DNA have been described. In general, DPC is removed via a two-step repair mechanism. First, cross-linked proteins are degraded by specific DPC proteases or by the proteasome, relieving steric hindrance. Second, the remaining DNA-peptide cross-links are eliminated in various DNA repair pathways. Delineating the molecular mechanisms of DHC repair would help target specific DNA repair proteins for therapeutic intervention to combat tumor resistance to chemotherapy and radiotherapy.

摘要

核小体是一段缠绕在组蛋白八聚体上的DNA。组蛋白与DNA之间的静电相互作用和氢键对于核小体核心颗粒的稳定组织以及染色质折叠成更紧密的结构至关重要,这些紧密结构通过对DNA的可控访问来调节基因表达。作为紧密结合的一个缺点,在基因毒性应激下,DNA可能会意外地与组蛋白以共价方式交联,产生高度有毒的DNA-组蛋白交联(DHC)。DHC是一种体积较大的损伤,会阻碍DNA转录、复制和修复,通常会导致致命后果。化疗药物顺铂以及电离辐射、紫外线辐射和内源性产生的反应性醛类,通过在DNA与组蛋白赖氨酸残基的侧链氨基之间形成稳定或短暂的共价键来产生DHC。DHC修复机制开始被揭示,并且已经描述了参与从DNA上去除交联组蛋白的DNA-蛋白质交联(DPC)修复机制的某些共同原则。一般来说,DPC通过两步修复机制被去除。首先,交联蛋白被特定的DPC蛋白酶或蛋白酶体降解,从而解除空间位阻。其次,剩余的DNA-肽交联在各种DNA修复途径中被消除。阐明DHC修复的分子机制将有助于靶向特定的DNA修复蛋白进行治疗干预,以对抗肿瘤对化疗和放疗的耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/7779557/661509814e34/fcell-08-607045-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验